Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to... see more

TSXV:BTI - Post Discussion

Bioasis Technologies Inc. > NASDAQ Listing
View:
Post by KayakerBC on Jun 27, 2022 6:25pm

NASDAQ Listing

I'm trying to get an idea of what a NASDAQ listing might look like.  I'm making up some numbers here that look reasonable to me. Just pure speculation. I'm using a stock price of 26¢ (up on a possible XB3-001 deal, start of a clinical trial, maybe other deals, etc.)

Looking at what's coming up for NASDAQ IPOs in the next couple of days, I see....

Symbol     Price           Shares
ONFO      4.50-5.50     1,700,000
BIAF         6.75             1,500,000

Those are IPOs, so let's say the BTI listing is for 1,200,000 ADRs at $5.00 US.  That's $6,000,000 US that goes to Bioasis or about $7,800,000 CAD (x1.3).  The 1.2M ADRs would represent 30,000,000 shares (assuming 26¢ CAD a share).  Each ADR would represent 25 shares. Shares outstanding would increase from current ~73M to ~103M.

If that example is realistic, it looks tolerable.  ~ $6M US (less fees and costs) for Bioasis to move programs forward. Float on the NASDAQ would be very low.  Overall shares outstanding would be 103M which is still quite decent.  For comparison, RVX has 249M shares outstanding and a stock price of 25¢.  

--------------------------------------------------------
1,200,000 x 5.00 = 6,000,000 US
6,000,000 x 1.3 = 7,800,000 CAD
7,800,000 / .26 =  30,000,000 shares
30,000,000 / 1,200,000 ADRs = 25 shares per ADR
73,000,000 + 30,000,000 = 103,000,000 shares outstanding

https://www.nasdaq.com/market-activity/ipos
Comment by narmac on Jun 27, 2022 8:06pm
Hummm,,,,like the idea,,,,and I think an assumption will be made by Mr Market in respect to what the market cap should look like based on where we are with our science and what risk is inherent in the assumption,,,,if we actually do make it to the NASDAQ it is assumed a speculative market cap would be assigned and adjusted accordingly, as deals and licenses and trial adavancements come into the ...more  
Comment by JDavenport on Jun 27, 2022 9:06pm
If a deal for xB3-001 is worth only a share price of 26¢, an addition of 9¢ to today's close, then there will never be any real value for xB3 and Bioasis. My guess is that Ladenburg Thalmann is demanding, to the extent they can demand, that no move to Nasdaq can happen without a substantial storyboard, meaning substantial news before, during and after the move to Nasdaq. I agree ...more  
Comment by Georgeparros on Jun 28, 2022 9:56am
I think you're spot on, jd.
Comment by LOOPA441 on Jun 28, 2022 10:22am
Do you beleive the Q4 timeline? The previous regime spoke about Nasdaq as well...
Comment by G1945V on Jun 28, 2022 8:45am
KBC, need a bigger float south of the border: 2,920,000 x 5.00 = 14,600,000 US 14,600,000 x 1.3 = 18,980,000 CAD 18,980,000 / .26 =  73,000,000 shares 73,000,000 / 2,920,000 ADRs = 25 shares per ADR 73,000,000 + 73,000,000 = 146,000,000 shares outstanding    ...more  
Comment by fuzzyjr on Jun 28, 2022 11:56am
"For comparison, RVX has 249M shares outstanding and a stock price of 25"    So which SP, rv or Bti do you believe will show the biggest gain by year end 2022? Ive gone back & forth on this many times - to be honest I'm still not sure. prob end up being zenith of all things. I'd like to be in even heavier on the one that pops first.Guess most would ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities